Diabetes 52:315-320, 2003
© 2003 by the American Diabetes Association, Inc.
Hyperactivity and Reduced Energy Cost of Physical Activity in Serotonin 5-HT2C Receptor Mutant Mice
Katsunori Nonogaki1,
Luna Abdallah1,
Evan H. Goulding1,
Stephen J. Bonasera1, and
Laurence H. Tecott, 1
1 From the Department of Psychiatry and Center for Neurobiology and Psychiatry, University of California, San Francisco, San Francisco, California
We have observed late-onset obesity in mutant mice lacking the serotonin 5-HT2C receptor. Despite chronically elevated food intake, young adult mutants exhibit neither elevated adiposity nor altered glucose or fat homeostasis. However, obesity subsequently develops after 6 months of age without increases in their level of hyperphagia. In this study, we investigated determinants of energy expenditure in 5-HT2C receptor mutant mice. Young adult mutants displayed patterns of elevated activity levels that were enhanced by fasting and tightly associated with repeated visits to a food source. Surprisingly, subsequent obesity development occurred despite persisting locomotor hyperactivity and without age-related declines in resting metabolic rate. Rather, substantial reductions in the energy cost of locomotor activity (LA) were observed in 5-HT2C receptor mutant mice. Moreover, both mutant and wild-type mice displayed age-related declines in the energy cost of LA, indicating that this process may be regulated by both aging and serotonergic signaling. These results indicate that a mutation of the 5-HT2C receptor gene (htr2c) increases LA, which contributes to the maintenance of normal body composition in young adult mutants despite their hyperphagia. Moreover, age-dependent reductions in the energy cost of physical activity could contribute to the subsequent development of late-onset obesity in 5-HT2C receptor mutant mice.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. S. Garfield and L. K. Heisler
Pharmacological targeting of the serotonergic system for the treatment of obesity
J. Physiol.,
January 1, 2009;
587(1):
49 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawahara, A. Grimberg, S. Teegarden, C. Mombereau, S. Liu, T. L. Bale, J. A. Blendy, and K. Nishikura
Dysregulated Editing of Serotonin 2C Receptor mRNAs Results in Energy Dissipation and Loss of Fat Mass
J. Neurosci.,
November 26, 2008;
28(48):
12834 - 12844.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nonogaki, K. Nozue, and Y. Oka
Social Isolation Affects the Development of Obesity and Type 2 Diabetes in Mice
Endocrinology,
October 1, 2007;
148(10):
4658 - 4666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. L. Sullivan, F. H. Koegler, and J. L. Cameron
Individual differences in physical activity are closely associated with changes in body weight in adult female rhesus monkeys (Macaca mulatta)
Am J Physiol Regulatory Integrative Comp Physiol,
September 1, 2006;
291(3):
R633 - R642.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Graham, D. O. Perkins, L. J. Edwards, R. C. Barrier Jr., J. A. Lieberman, and J. B. Harp
Effect of Olanzapine on Body Composition and Energy Expenditure in Adults With First-Episode Psychosis
Am J Psychiatry,
January 1, 2005;
162(1):
118 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Diabetes Association.
|
|
| |
|